Form 4: Teva Pharmaceutical Industries: Officer Weiss Reports Share Disposal Following RSU Vesting
SEC Form 4 Filing
Amir Weiss, Chief Accounting Officer of Teva Pharmaceutical Industries, reports the disposal of 3,219 ordinary shares following the vesting of restricted share units on February 28, 2024.
Summary
- Amir Weiss, Chief Accounting Officer of Teva Pharmaceutical Industries, filed a Form 4 on March 1, 2024, reporting changes in beneficial ownership.
- On February 28, 2024, Weiss disposed of 3,219 ordinary shares due to the vesting of restricted share units (RSUs).
- These RSUs were granted on February 28, 2020, and vested in four equal installments on February 28th of 2021, 2022, 2023, and 2024.
- Following the reported transaction, Weiss beneficially owns 13,895 ordinary shares.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. The vesting of RSUs is a common form of executive compensation.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a routine disposal of shares related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/28/2020 | Restricted share units were granted. |
| 02/28/2021 | First vesting date of restricted share units (3,219 shares). |
| 02/28/2022 | Second vesting date of restricted share units (3,219 shares). |
| 02/28/2023 | Third vesting date of restricted share units (3,219 shares). |
| 02/28/2024 | Final vesting date of restricted share units (3,219 shares) and disposal of shares. |
| 03/01/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.